JAMA Network
What The Study Did: Researchers examined whether Medicaid patients in Wisconsin with opioid use disorder experienced decreased access to treatment, including receiving buprenorphine and urine drug testing during the COVID-19 pandemic.
Authors: Alyssa Shell Tilhou, M.D., Ph.D., of the Boston University School of Medicine/Boston Medical Center, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2022.0093)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
